| 摘要 |
<p>Anti-influenza drugs containing as the active ingredient ambroxol, bromhexine or pharmacologically acceptable salts thereof. Namely, remedies or preventives for influenza characterized by having an anti-influenza effect via the promotion of the secretion of a biological anti-influenza virus factor contained in the airway fluid. These drugs are characterized by inhibiting the growth of an influenza virus in the airway by promoting the secretion of an inhibitor for a protease in the airway which induces the infectivity of the influenza virus. These drugs are also characterized by inhibiting the growth of an influenza virus in the airway by promoting the secretion of mucosal immunity substances IgA and IgG. These drugs are further characterized by inhibiting the release of inflammatory cytokines in the airway.</p> |
